IgA nephropathy and celiac disease: pathogenetic relationship of diseases and the possibility of a gluten-free diet
https://doi.org/10.51793/OS.2021.24.8.003
Abstract
According to the world literature IgA nephropathy is most often considered as an idiopathic form of primary glomerulonephritis, however, in some cases, the disease can be secondary and pathogenetically associated with liver diseases (cirrhosis of any etiology), lung diseases (sarcoidosis, etc.), systemic and autoimmune diseases (hemorrhagic vasculitis, systemic lupus erythematosus, etc.), as well as inflammatory bowel diseases (Crohn's disease, ulcerative colitis, celiac disease). In the context of possible improvement in the outcomes of nephropathy, as well as new treatment methods the association of IgA nephropathy with celiac disease is particularly noteworthy. There is evidence of potential pathogenetic links between these diseases, where gluten in some patients is probably a trigger factor in the development of glomerulonephritis. According to the world literature, the prevalence of celiac disease in the general population is 0,5-1%, depending on the geographical region, and increases to 4% in patients with IgA nephropathy. The influence of celiac disease on the clinical course of IgA nephropathy, the study of possible pathogenetic mechanisms of the relationship, the prospects and possibilities of the gluten-free diet in the treatment of IgA nephropathy determine the relevance of the review topic.
About the Authors
M. E. MantsaevaRussian Federation
Moscow
A. G. Borisov
Russian Federation
Moscow
M. A. Smirnova
Russian Federation
Moscow
A. A. Stremouhov
Russian Federation
Moscow
References
1. Barratt J., Feehally J. IgA nephropathy // J. Am. Soc. Nephrol. 2005; 7 (16): 2088-2097.
2. Manno C. и др. A Novel Simpler Histological Classification for Renal Survival in IgA Nephropathy: A Retrospective Study // Am. J. Kidney Dis. 2007; 6 (49): 763-775.
3. Shilov Ye. M. Nefrologiya. Klinicheskiye rekomendatsii / Pod red. Ye. M. Shilova, A. V. Smirnova, N. L. Kozlovskoy. [Clinical guidelines] M.: GEOTAR-Media, 2016. P. 816.
4. Soares M. F. An update on pathology of IgA nephropathy // J. Bras. Nefrol. 2016; 4 (38): 435-440.
5. Komissarov K. S., Yurkevich M. Yu., Zafranskaya M. M., Pilotovich V. S. Sovremennyye predstavleniya o patogeneze immunoglobulin A-nefropatii [Modern concepts of the pathogenesis of immunoglobulin A-nephropathy] Nefrologiya. 2014; 2 (18): 47-54.
6. Feehally J., Allen A. C. Structural features of IgA molecules which contribute to IgA nephropathy // J. Nephrol. 1999; 2: 59-65.
7. Hiki Y. и др. Underglycosylation of IgAl hinge plays a certain role for its glomerular deposition in IgA nephropathy // J. Am. Soc. Nephrol. 1999; 4 (10): 760-769.
8. Yeo S. C., Cheung C. K., Barratt J. New insights into the pathogenesis of IgA nephropathy // Pediatr. Nephrol. 2018; 5 (33): 763-777.
9. Lemley K. V. и др. Prediction of early progression in recently diagnosed IgA nephropathy // Nephrol. Dial. Transplant. 2008; 1 (23): 213-222.
10. Wyatt R. J., Julian B. A. MEdical progress: IgA nephropathy // N. Engl. J. Med. 2013; 25 (368): 2402-24014.
11. Dadyk Ye. A. i dr. IgA-nefropatiya: morfologicheskaya kharakteristika, osobennosti klinicheskogo techeniya i prognoz [IgA-nephropathy: morphological characteristics, clinical course features and prognosis] Vestnik neotlozhnoy i vosstanovitel'noy meditsiny. 2008; 2 (9): 171-178.
12. Laville M., Alamartine E. Treatment options for IgA nephropathy in adults: A proposal for evidence-based strategy // Nephrol. Dial. Transplant. 2004; 8 (19): 1947-1951.
13. Maixnerova D. и др. Markers for the progression of IgA nephropathy // J. Nephrol. 2016; 4 (29): 535-541.
14. Dobronravov V. A. i dr. Immunoglobulin A-nefropatiya v rossiyskoy populyatsii: klinikomorfologicheskaya prezentatsiya i otdalennyy prognoz [Immunoglobulin A-nephropathy in the Russian population: clinical and morphological presentation and long-term prognosis] Nefrologiya. 2019; 6: 45-60.
15. Malkoch A. V., Bel'mer S. V. Nefropatii pri tseliakii [Nephropathy in celiac disease] The Lechaschi Vrach Journal. 2012; 8: 19-21.
16. Boonpheng B., Cheungpasitporn W., Wijarnpreecha K. Renal disease in patients with celiac disease // Minerva Med. 2018; 2: 126-140.
17. Wijarnpreecha K. и др. Celiac disease and the risk of kidney diseases: A systematic review and metaanalysis // Dig. Liver Dis. 2016; 12 (48): 1418-1424.
18. Sabel'nikova Ye. A. i dr. Tseliakiya u pozhilykh [Celiac disease in the elderly] Eksperimental'naya i klinicheskaya gastroenterologiya. 2010; 12 (173): 48-53.
19. Lazebnik L. B., Tkachenko Ye. I., Oreshko L. S. i soavt. Rekomendatsii po diagnostike i lecheniyu tseliakii vzroslykh [Recommendations for the diagnosis and treatment of celiac disease in adults] Klinicheskaya gastroenterologiya. 2015; 5 (117): 3-12.
20. Krums L. M., Parfenov A. I. Sovremennaya kontseptsiya tseliakii [The modern concept of celiac disease] RMJ. 2003; 2: 81-85.
21. Cabel'nikova Ye. A. Glyutenchuvstvitel'naya tseliakiya (obzor literatury) [Gluten-sensitive celiac disease (literature review)] Eksperimental'naya i klinicheskaya gastroenterologiya. 2008; 4: 39-49.
22. Admou B. и др. Atypical celiac disease: From recognizing to managing // Gastroenterol. Res. Pract. 2012; 12 (10): 90-96.
23. Parfenov A. I., Krums L. M., Sabel'nikova Ye. A. Sovremennaya kontseptsiya, definitsiya i klassifikatsiya tseliakii [Modern concept, definition and classification of celiac disease] Materialy V s"yezda nauchnogo obshchestva gastroenterologov Rossii. 2005. p. 473-475.
24. Parfenov A. I., Sabel'nikova Ye. A., Neyman K. P. i dr. Tseliakiya i pechen' (obzor) [Celiac disease and liver (review)] Ter. arkhiv. 2006; 1: 70-73
25. The Russian consensus on diagnosis and treatment of coeliac disease in children and adults // Alm. Clin. Med. 2016; 6 (44): 661-668.
26. Parfenov A. I., Sabel'nikova Ye. A., Krums L. M. i dr. Glyutenchuvstvitel'naya tseliakiya i profilaktika autoimmunnykh i onkologicheskikh zabolevaniy [Gluten-sensitive celiac disease and prevention of autoimmune and oncological diseases] Ter. arkhiv. 2007; 2: 5-11.
27. Shumilov P. V. и др. Modern understanding of celiac disease pathogenetic mechanisms: Defining role in course clinical variants // Pediatr. Zhurnal im G. N. Speranskogo. 2016; 6 (95): 110-121.
28. Maksimov V. A., Dalidovich K. K., Chernyshev A. L., Kulikov A. G., Neronov V. A. Diagnostika i lechenie zabolevanii organov pischevareniya [Diagnostics and treatment of diseases of the digestive system] M.: Adamant, 2016. 848
29. Wyatt R. J., Julian B. A. Mеdical progress: IgA nephropathy // N. Engl. J. Med. 2013; 25 (368): 2402-2414.
30. Helin H., Mustonen J., Reunala T., Pasternack A. IgA nephropathy associated with celiac disease and dermatitis herpetiformis // Arch Pathol Lab Med. 1983; 6: 324-327.
31. Welander A. и др. Increased risk of IgA nephropathy among individuals with celiac disease // J. Clin. Gastroenterol. 2013; 8 (47): 678-683.
32. Emancipator B. S. N., Gallo G. R., Lamm M. E. Experimental IgA nephropathy induced by oral immunization // J Exp Med. 1983; 2 (157): 572-582.
33. Tomino Y. Diagnosis and treatment of patients with IgA nephropathy in Japan // Kidney Res. Clin. Pract. 2016; 4 (35): 197-203.
34. Coppo R. The Gut-Renal Connection in IgA Nephropathy // Semin. Nephrol. 2018; 5 (38): 504-512.
35. Coppo R. и др. Gluten-induced experimental IgA glomerulopathy // Lab Invest. 1989; 4: 499-506.
36. Coppo R. The intestine-renal connection in IgA nephropathy // Nephrol. Dial. Transplant. 2015; 3 (30): 360-366.
37. Coppo R., Roccatello D., Amore A. et al. Effects of a gluten-free diet in primary IgA nephropathy // Clin Nephrol. 1990; 33: 72-86.
38. Papista C. и др. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction // Kidney Int. 2015; 2 (88): 276-285.
Review
For citations:
Mantsaeva M.E., Borisov A.G., Smirnova M.A., Stremouhov A.A. IgA nephropathy and celiac disease: pathogenetic relationship of diseases and the possibility of a gluten-free diet. Lechaschi Vrach. 2021;(8):18-24. (In Russ.) https://doi.org/10.51793/OS.2021.24.8.003
JATS XML


















